Access to anti-retroviral drugs, female in Colombia
Colombia: Access to anti-retroviral drugs, female was 77.0% in 2023. ◆ Volatile
Access to anti-retroviral drugs, female in Colombia, 2000–2023
Source: UNAIDS estimates. Measured in %.
Analysis
In 2023, access to anti-retroviral drugs, female in Colombia stood at 77.0%. That is the highest value across all 24 years on record.
Compared with earlier readings it is up 1.3% on the previous year and up 63.8% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Colombia peaked at 77.0% in 2023 and was at its lowest, 0.0%, in 2000.
That places Colombia 63rd out of 141 countries with data for 2023, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Colombia, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 2.0% | — |
| 2002 | 4.0% | +100.0% |
| 2003 | 5.0% | +25.0% |
| 2004 | 7.0% | +40.0% |
| 2005 | 8.0% | +14.3% |
| 2006 | 15.0% | +87.5% |
| 2007 | 13.0% | -13.3% |
| 2008 | 13.0% | +0.0% |
| 2009 | 15.0% | +15.4% |
| 2010 | 23.0% | +53.3% |
| 2011 | 32.0% | +39.1% |
| 2012 | 39.0% | +21.9% |
| 2013 | 47.0% | +20.5% |
| 2014 | 53.0% | +12.8% |
| 2015 | 60.0% | +13.2% |
| 2016 | 64.0% | +6.7% |
| 2017 | 61.0% | -4.7% |
| 2018 | 67.0% | +9.8% |
| 2019 | 74.0% | +10.4% |
| 2020 | 76.0% | +2.7% |
| 2021 | 73.0% | -3.9% |
| 2022 | 76.0% | +4.1% |
| 2023 | 77.0% | +1.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 8.2% | 0.0% | 15.0% | 10 |
| 2010s | 52.0% | 23.0% | 74.0% | 10 |
| 2020s | 75.5% | 73.0% | 77.0% | 4 |
Countries ranked near Colombia
More gender data for Colombia
- Child population (UN estimates and projections) 10,499 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.3937 % change on previous year (2030)
- Population 45,238 (2030)
- Working-age population (UN estimates and projections) 45,238 (2030)
- Population (UN estimates and projections), annual growth rate 1.02 % change on previous year (2030)
- Age population, age 00, female, interpolated 339,895 (2025)
- Age population, age 00, male, interpolated 354,522 (2025)
- Age population, age 01, female, interpolated 343,649 (2025)
- Age population, age 01, male, interpolated 358,222 (2025)
- Age population, age 02, female, interpolated 346,714 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Colombia?
- Access to anti-retroviral drugs, female in Colombia was 77.0% in 2023, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Colombia?
- The highest recorded value was 77.0% in 2023.
- What is the lowest access to anti-retroviral drugs, female recorded in Colombia?
- The lowest recorded value was 0.0% in 2000.
- How does Colombia rank for access to anti-retroviral drugs, female?
- Colombia ranks 63rd out of 141 countries with data for 2023.
- Is access to anti-retroviral drugs, female rising or falling in Colombia?
- Over the last ten years it is up 63.8%. The long-run trend across the full record is volatile.
- Where does this Colombia data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.